Journal Article

Neonatal and maternal outcomes following SARS-CoV-2 infection and COVID-19 vaccination: a population-based matched cohort study

McCowan, Colin, Katikireddi, Srinivasa Vittal, Carruthers, Jade, Lindsay, Laura, Hopcroft, Lisa E. M., Hopkins, Leanne, Wood, Rachael, Goulding, Anna, McCabe, Ronan, Calvert, Clara, Shi, Ting, Donaghy, Jack, McLaughlin, Terry, Taylor, Bob, Stock, Sarah J., Bhaskaran, Krishnan, Moore, Emily, Robertson, Chris, Denny, Cheryl, Simpson, Colin R., Sheikh, Aziz

2023

Overview

Understanding the impact of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy on neonatal and maternal outcomes informs clinical decision-making. Here we report a national, population-based, matched cohort study to investigate associations between SARS-CoV-2 infection and, separately, COVID-19 vaccination just before or during pregnancy and the risk of adverse neonatal and maternal outcomes among women in Scotland with a singleton pregnancy ending at ≥20 weeks gestation. Neonatal outcomes are stillbirth, neonatal death, extended perinatal mortality, preterm birth (overall, spontaneous, and provider-initiated), small-for-gestational age, and low Apgar score. Maternal outcomes are admission to critical care or death, venous thromboembolism, hypertensive disorders of pregnancy, and pregnancy-related bleeding. We use conditional logistic regression to derive odds ratios adjusted for socio-demographic and clinical characteristics (aORs). We find that infection is associated with an increased risk of preterm (aOR=1.36, 95% Confidence Interval [CI] = 1.16–1.59) and very preterm birth (aOR = 1.90, 95% CI 1.20–3.02), maternal admission to critical care or death (aOR=1.72, 95% CI = 1.39–2.12), and venous thromboembolism (aOR = 2.53, 95% CI = 1.47–4.35). We find no evidence of increased risk for any of our outcomes following vaccination. These data suggest SARS-CoV-2 infection during pregnancy is associated with adverse neonatal and maternal outcomes, and COVID-19 vaccination remains a safe way for pregnant women to protect themselves and their babies against infection. The impacts of SARS-CoV-2 infection and COVID-19 vaccination in pregnancy are not fully understood. Here, the authors perform a cohort study using data from Scotland and find that infection was associated with increased risk of preterm birth and some adverse maternal outcomes, but there was no evidence of adverse outcomes associated with vaccination.

• Publisher: Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
• Subject: 631/326/590 / 631/326/596/4130 / 692/308/174 / 692/699/255 / Adult / Apgar score / Birth / Childbirth & labor / Cohort analysis / Cohort Studies / Confidence intervals / COVID-19 / COVID-19 - pathology / COVID-19 vaccines / COVID-19 Vaccines - adverse effects / Critical care / Death / Decision making / Female / Gestational age / Humanities and Social Sciences / Humans / Immunization / Infant, Newborn / Infections / Mortality / multidisciplinary / Neonates / Population studies / Population-based studies / Pregnancy / Pregnancy Complications, Infectious - pathology / Pregnancy Outcome / Premature birth / Risk / Science / Science (multidisciplinary) / Severe acute respiratory syndrome coronavirus 2 / Small for gestational age / Statistical analysis / Thromboembolism / Vaccination